Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Day One Biopharmaceuticals (DAWN) FCF Margin: 2024-2025

Historic FCF Margin for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Sep 2025 value amounting to -14.59%.

  • Day One Biopharmaceuticals' FCF Margin fell 12658.00% to -14.59% in Q3 2025 from the same period last year, while for Sep 2025 it was -104.13%, marking a year-over-year change of. This contributed to the annual value of -74.80% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Day One Biopharmaceuticals' FCF Margin stood at -14.59%, which was up 78.61% from -68.20% recorded in Q2 2025.
  • Day One Biopharmaceuticals' 5-year FCF Margin high stood at 111.99% for Q3 2024, and its period low was -1,271.11% during Q2 2024.
  • For the 2-year period, Day One Biopharmaceuticals' FCF Margin averaged around -268.14%, with its median value being -118.42% (2024).
  • Examining YoY changes over the last 5 years, Day One Biopharmaceuticals' FCF Margin showed a top increase of 120,290bps in 2025 and a maximum decrease of 12,658bps in 2025.
  • Quarterly analysis of 2 years shows Day One Biopharmaceuticals' FCF Margin stood at -168.65% in 2024, then plummeted by 12,658bps to -14.59% in 2025.
  • Its FCF Margin stands at -14.59% for Q3 2025, versus -68.20% for Q2 2025 and -198.29% for Q1 2025.